Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Campaign Mounts to Curb Counterfeit Drugs

Import controls and risk strategies aim to promote quality and spur new drug development.
Sep 2, 2012

Import controls and risk strategies aim to promote quality and spur new drug development.

Healthcare Reform is Given the Go-Ahead: Now What?

No matter the upside or downside to the Affordable Care Act, there's work to be done.
Aug 2, 2012

No matter the upside or downside to the Affordable Care Act, there's work to be done.

FDA User-Fee Legislation Sets Stage for Change

Import controls and risk strategies aim to promote quality and spur new drug development.
Aug 2, 2012

Import controls and risk strategies aim to promote quality and spur new drug development.

International AIDS Conference Highlights ARV Advances

Jul 31, 2012

Prominent scientists and political leaders at the International AIDS Conference in Washington, D.C., in late July were optimistic for the first time about bringing an end to the global AIDS pandemic.

FDA Adopts New Strategies to Oversee Global Economy

A Q&A with FDA Deputy Commissioner Deborah Autor.
Jul 2, 2012

A Q&A with FDA Deputy Commissioner Deborah Autor.

Commentary: Healthcare Reform is Ruled Constitutional

Jun 29, 2012

In a 5–4 vote, the Supreme Court has ruled in favor of the Constitutionality of the Affordable Care Act.

Congress Move Promptly to Finalize FDA User Fees

Jun 20, 2012

Legislation fails to establish national track-and-trace system, but tackles shortages.

Manufacturers Back Innovation Initiatives

New legislation, government programs aim to bolster drug discovery and reduce regulatory hurdles.
Jun 2, 2012

New legislation, government programs aim to bolster drug discovery and reduce regulatory hurdles.

FDA Explores Options to Expand Access to Non-Rx Drugs

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
May 2, 2012

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here